| Year |
Citation |
Score |
| 2018 |
Thriemer K, Bobogare A, Ley B, Gudo CS, Alam MS, Anstey NM, Ashley E, Baird JK, Gryseels C, Jambert E, Lacerda M, Laihad F, Marfurt J, Pasaribu AP, Poespoprodjo JR, ... ... McCarthy J, et al. Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working Group. Malaria Journal. 17: 241. PMID 29925430 DOI: 10.1186/S12936-018-2380-8 |
0.303 |
|
| 2018 |
Reuling IJ, van de Schans LA, Coffeng LE, Lanke K, Meerstein-Kessel L, Graumans W, van Gemert GJ, Teelen K, Siebelink-Stoter R, van de Vegte-Bolmer M, de Mast Q, van der Ven AJ, Ivinson K, Hermsen CC, de Vlas S, ... ... McCarthy J, et al. A randomized feasibility trial comparing four antimalarial drug regimens to inducegametocytemia in the controlled human malaria infection model. Elife. 7. PMID 29482720 DOI: 10.7554/Elife.31549 |
0.327 |
|
| 2016 |
Griffin P, Pasay C, Elliott S, Sekuloski S, Sikulu M, Hugo L, Khoury D, Cromer D, Davenport M, Sattabongkot J, Ivinson K, Ockenhouse C, McCarthy J. Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission. Plos Neglected Tropical Diseases. 10: e0005139. PMID 27930652 DOI: 10.1371/Journal.Pntd.0005139 |
0.308 |
|
| 2014 |
Cheng Q, Gatton ML, Barnwell J, Chiodini P, McCarthy J, Bell D, Cunningham J. Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3: a review and recommendations for accurate reporting. Malaria Journal. 13: 283. PMID 25052298 DOI: 10.1186/1475-2875-13-283 |
0.32 |
|
| 2013 |
von Seidlein L, Auburn S, Espino F, Shanks D, Cheng Q, McCarthy J, Baird K, Moyes C, Howes R, Ménard D, Bancone G, Winasti-Satyahraha A, Vestergaard LS, Green J, Domingo G, et al. Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report. Malaria Journal. 12: 112. PMID 23537118 DOI: 10.1186/1475-2875-12-112 |
0.301 |
|
| 2012 |
McCarthy J. Elimination challenges in the Pacific: vivax and submicroscopic parasitemia Malaria Journal. 11. DOI: 10.1186/1475-2875-11-S1-O26 |
0.328 |
|
| 2010 |
Baker J, Ho MF, Pelecanos A, Gatton M, Chen N, Abdullah S, Albertini A, Ariey F, Barnwell J, Bell D, Cunningham J, Djalle D, Echeverry DF, Gamboa D, Hii J, ... ... McCarthy J, et al. Global sequence variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: implications for the performance of malaria rapid diagnostic tests. Malaria Journal. 9: 129. PMID 20470441 DOI: 10.1186/1475-2875-9-129 |
0.303 |
|
| 2009 |
Daveson AJM, Jones D, Mcsorley H, Gaze S, Mccarthy J, Clouston A, Pascoe A, Macdonald G, Speare R, Anderson R, Loukas A, Croese J. A phase 2A randomized double blinded placebo controlled study evaluating immunity and gluten sensitivity by inoculating coeliac disease patients with the human hookworm necator americanus Journal of Gastroenterology and Hepatology. 24. PMID 19807831 DOI: 10.1111/J.1440-1746.2009.06050.X |
0.443 |
|
| 2006 |
Lee N, Baker J, Andrews KT, Gatton ML, Bell D, Cheng Q, McCarthy J. Effect of sequence variation in Plasmodium falciparum histidine-rich protein 2 on binding of specific monoclonal antibodies: Implications for rapid diagnostic tests for malaria Journal of Clinical Microbiology. 44: 2773-2778. PMID 16891491 DOI: 10.1128/Jcm.02557-05 |
0.302 |
|
| 2005 |
Baker J, McCarthy J, Gatton M, Kyle DE, Belizario V, Luchavez J, Bell D, Cheng Q. Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests. The Journal of Infectious Diseases. 192: 870-7. PMID 16088837 DOI: 10.1086/432010 |
0.305 |
|
| 2001 |
McCarthy J, Moore TA. Emerging helminth zoonoses. International Journal For Parasitology. 30: 1351-60. PMID 11113260 DOI: 10.1016/S0020-7519(00)00122-3 |
0.305 |
|
| Show low-probability matches. |